County
Nash County Emergency Medical Services
The current listed document is more than 24 months old and may be outdated.
Drugs and doses39
A–C Acetaminophen, Activated Charcoal, Adenosine, Amiodarone, Aspirin, Atropine, Calcium Chloride, Calcium Gluconate8
Acetaminophen
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Fever | adult | 325–1000 mg | PO | not captured | standing | page 24 |
| Fever | peds | 15 mg/kg | PO | not captured | standing | page 24 |
| Mild to moderate pain | adult | 325–1000 mg | PO | not captured | standing | page 25 |
| Mild to moderate pain | peds | 15 mg/kg | PO | not captured | standing | page 25 |
Activated Charcoal
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 1 g/kg | PO | not captured | standing | page 152 |
| Other | peds | 1 g/kg | PO | not captured | standing | page 152 |
Adenosine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Narrow-complex tachycardia | adult | 12 mg | IV/IO | not captured | standing | page 69 |
| Narrow-complex tachycardia | peds | 0.1 mg/kg | IV/IO | not captured | standing | page 69 |
Amiodarone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Narrow-complex tachycardia | adult | 150 mg | IV/IO | not captured | standing | page 69 |
| Wide-complex tachycardia | adult | 150 mg | IV/IO | not captured | standing | page 71 |
| VF / pulseless VT | adult | 300 mg | IV/IO | not captured | standing | page 75 |
| VF / pulseless VT | peds | 5 mg/kg | IV/IO | not captured | standing | page 75 |
| VF / pulseless VT | peds | 5 mg/kg | IV/IO | not captured | standing | page 131 |
Aspirin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Mild to moderate pain | adult | 324–650 mg | PO | not captured | standing | page 25 |
Atropine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Bradycardia | adult | 1 mg | IV/IO | not captured | standing | page 61 |
| Bradycardia | peds | 0.02 mg/kg | IV/IO | not captured | standing | page 61 |
| Nerve agent exposure | adult | 2 mg | IM | not captured | standing | page 154 |
| Nerve agent exposure | peds | 0.5 mg | IM | not captured | standing | page 154 |
Calcium Chloride
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Beta-blocker / calcium-channel-blocker overdose | adult | 1 g | IV/IO | not captured | standing | page 152 |
| Beta-blocker / calcium-channel-blocker overdose | peds | 1 g | IV/IO | not captured | standing | page 152 |
| Hyperkalemia | adult | 1 g | IV/IO | not captured | standing | page 91 |
| Hyperkalemia | peds | 1 g | IV/IO | not captured | standing | page 91 |
Calcium Gluconate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Beta-blocker / calcium-channel-blocker overdose | adult | 2 g | IV/IO | not captured | standing | page 152 |
| Beta-blocker / calcium-channel-blocker overdose | peds | 1 g | IV/IO | not captured | standing | page 152 |
| Hyperkalemia | adult | 2 g | IV/IO | not captured | standing | page 91 |
| Hyperkalemia | peds | 1 g | IV/IO | not captured | standing | page 91 |
D–F Dexamethasone, Dextrose, Diazepam, Diltiazem, Diphenhydramine, Dopamine, Enalapril, Epinephrine, Fentanyl9
Dexamethasone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Adrenal crisis | adult | 10 mg | IV/IO/IM | not captured | standing | page 95 |
| Adrenal crisis | peds | 10 mg | IV/IO/IM | not captured | standing | page 95 |
Dextrose
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypoglycemia | adult | 12.5 g | IV/IO | not captured | standing | page 89 |
| Hypoglycemia | peds | 5 mL/kg | IV/IO | not captured | standing | page 89 |
Diazepam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 2 mg | IV/IM/SQ | not captured | standing | page 164 |
Diltiazem
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Narrow-complex tachycardia | adult | 0.25 mg/kg | IV/IO | not captured | standing | page 69 |
Diphenhydramine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 25–50 mg | PO | not captured | standing | page 87 |
| Anaphylaxis | adult | 25–50 mg | IV/IO/IM | not captured | standing | page 87 |
| Anaphylaxis | peds | 1 mg/kg | PO | not captured | standing | page 87 |
| Anaphylaxis | peds | 1 mg/kg | IV/IO/IM | not captured | standing | page 87 |
| Dystonic reaction | adult | 50 mg | IV/IO/IM/PO | not captured | standing | page 38 |
| Dystonic reaction | peds | 1 mg/kg | IV/IO/IM/PO | not captured | standing | page 38 |
Dopamine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Bradycardia | adult | 2–20 mcg/kg | IV/IO | not captured | standing | page 61 |
| Hypotension / shock | adult | 5–20 mcg/kg | IV/IO | not captured | standing | page 139 |
| Hypotension / shock | peds | 5–20 mcg/kg | IV/IO | not captured | standing | page 139 |
Enalapril
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| CHF / pulmonary edema | adult | 1.25 mg | IV/IO | not captured | standing | page 67 |
Epinephrine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 0.3–0.5 mg | IM | not captured | standing | page 47 |
| Anaphylaxis | peds | 0.01 mg/kg | IM | not captured | standing | page 47 |
| Bradycardia | adult | 1–10 mcg | IV/IO | not captured | standing | page 61 |
| Bradycardia | peds | 0.01 mg/kg | IV/IO | not captured | standing | page 61 |
| Cardiac arrest | adult | 1 mg | IV/IO | not captured | standing | page 59 |
| Cardiac arrest | peds | 0.01 mg/kg | IV/IO | not captured | standing | page 59 |
| Respiratory distress | peds | 1 mg | NEB | not captured | standing | page 47 |
Fentanyl
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Severe pain | adult | 50–100 mcg | IV/IO/IM | not captured | standing | page 25 |
| Severe pain | peds | 1 mcg/kg | IV/IO/IM | not captured | standing | page 25 |
| Post-intubation sedation | adult | 50–75 mcg | IV/IO | not captured | standing | page 55 |
| Post-intubation sedation | peds | 1 mcg/kg | IV/IO | not captured | standing | page 55 |
G–L Glucagon, Haloperidol, Hydrocortisone, Hydromorphone, Ibuprofen, Ipratropium, Ketamine, Ketorolac, Lidocaine, Lorazepam10
Glucagon
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Beta-blocker / calcium-channel-blocker overdose | adult | 2–4 mg | IV/IO/IM | not captured | standing | page 152 |
| Beta-blocker / calcium-channel-blocker overdose | peds | 0.1 mg/kg | IV/IO/IM | not captured | standing | page 152 |
| Hypoglycemia | peds | 0.1 mg/kg | IM | not captured | standing | page 89 |
Haloperidol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 2 mg | IV/IM/SQ | not captured | standing | page 164 |
| Nausea / vomiting | adult | 2 mg | IV/IM/SQ | not captured | standing | page 164 |
Hydrocortisone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Adrenal crisis | adult | 100 mg | IV/IO/IM | not captured | standing | page 95 |
| Adrenal crisis | peds | 25 mg | IV/IO/IM | not captured | standing | page 95 |
Hydromorphone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Severe pain | adult | 0.5 mg | IV/IM/SQ | not captured | standing | page 164 |
Ibuprofen
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Fever | adult | 400–600 mg | PO | not captured | standing | page 24 |
| Fever | peds | 10 mg/kg | PO | not captured | standing | page 24 |
| Mild to moderate pain | adult | 400–600 mg | PO | not captured | standing | page 25 |
| Mild to moderate pain | peds | 10 mg/kg | PO | not captured | standing | page 25 |
Ipratropium
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Respiratory distress | adult | 0.5 mg | NEB | not captured | standing | page 47 |
| Respiratory distress | peds | 0.5 mg | NEB | not captured | standing | page 47 |
Ketamine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Post-intubation sedation | adult | 1.5–2 mg/kg | IV/IO | not captured | standing | page 55 |
Ketorolac
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Severe pain | adult | 15 mg | IV/IO | not captured | standing | page 25 |
| Severe pain | adult | 30 mg | IM | not captured | standing | page 25 |
| Sepsis | adult | 15 mg | IV/IO/IM | not captured | standing | page 33 |
Lidocaine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Wide-complex tachycardia | adult | 1 mg/kg | IV/IO | not captured | standing | page 71 |
| VF / pulseless VT | adult | 1 mg/kg | IV/IO | not captured | standing | page 75 |
Lorazepam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 0.5 mg | IV/IM/SQ | not captured | standing | page 164 |
| Nausea / vomiting | adult | 0.5 mg | IV/IM/SQ | not captured | standing | page 164 |
M–O Magnesium Sulfate, Methylprednisolone, Midazolam, Morphine, Naloxone, Nitroglycerin, Norepinephrine, Odansetron, Ondansetron9
Magnesium Sulfate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Respiratory distress | adult | 2 g | IV/IO | not captured | standing | page 47 |
| Respiratory distress | peds | 40 mg/kg | IV/IO | not captured | standing | page 47 |
| Wide-complex tachycardia | adult | 2 g | IV/IO | not captured | standing | page 73 |
| Wide-complex tachycardia | peds | 2 g | IV/IO | not captured | standing | page 73 |
Methylprednisolone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 125 mg | IV/IO | not captured | standing | page 87 |
| Anaphylaxis | peds | 2 mg/kg | IV/IO | not captured | standing | page 87 |
| Respiratory distress | adult | 125 mg | IV/IO/IM | not captured | standing | page 47 |
| Respiratory distress | peds | 2 mg/kg | IV/IO/IM | not captured | standing | page 47 |
Midazolam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 2.5 mg | IV/IO/IN | not captured | standing | page 40 |
| Agitation | peds | 0.1–0.2 mg/kg | IV/IO/IN | not captured | standing | page 40 |
| Hyperactive delirium | adult | 5 mg | IM | not captured | standing | page 41 |
| Hyperactive delirium | peds | 0.1–0.2 mg/kg | IM | not captured | standing | page 41 |
| Procedural sedation | adult | 2–2.5 mg | IV/IO/IM/IN | not captured | standing | page 15 |
| Procedural sedation | adult | 2.5 mg | IV/IO | not captured | standing | page 69 |
| Procedural sedation | peds | 0.1–0.2 mg/kg | IV/IO | not captured | standing | page 69 |
| Seizure | adult | 10 mg | IM | not captured | standing | page 29 |
| Seizure | adult | 2.5 mg | IV/IO | not captured | standing | page 29 |
| Seizure | peds | 0.2 mg/kg | IV/IO | not captured | standing | page 29 |
| Seizure | peds | 0.2 mg/kg | IM | not captured | standing | page 29 |
Morphine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Severe pain | adult | 4 mg | IV/IO/IM | not captured | standing | page 25 |
| Severe pain | peds | 0.1 mg/kg | IV/IO/IM | not captured | standing | page 25 |
| Post-intubation sedation | adult | 4 mg | IV/IO | not captured | standing | page 55 |
| Post-intubation sedation | peds | 0.1 mg/kg | IV/IO | not captured | standing | page 55 |
Naloxone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Opioid overdose | adult | 0.4–2 mg | IM/IN | not captured | standing | page 63 |
| Opioid overdose | adult | 0.4–2 mg | IV/IO/IM/IN/ET | not captured | standing | page 63 |
| Opioid overdose | peds | 0.1 mg/kg | IM/IN | not captured | standing | page 63 |
| Opioid overdose | peds | 0.1 mg/kg | IV/IO/IM/IN/ET | not captured | standing | page 63 |
Nitroglycerin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 0.4 mg | SL | not captured | standing | page 65 |
| CHF / pulmonary edema | adult | 0.4 mg | SL | not captured | standing | page 67 |
Norepinephrine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypotension / shock | peds | 0.1–1 mcg/kg | IV/IO | not captured | standing | page 139 |
| Sepsis | adult | 1–10 mcg | IV/IO | not captured | standing | page 33 |
| Sepsis | peds | 0.1–1 mcg/kg | IV/IO | not captured | standing | page 33 |
Odansetron
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nausea / vomiting | adult | 4 mg | IV/IO/IM/ODT | not captured | standing | page 13 |
| Nausea / vomiting | peds | 0.2 mg/kg | IV/IO/IM/ODT | not captured | standing | page 13 |
Ondansetron
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nausea / vomiting | adult | 4 mg | IV/IM | not captured | standing | page 164 |
P–R Pralidoxime, Promethazine2
Pralidoxime
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nerve agent exposure | adult | 600 mg | IV/IO/IM | not captured | standing | page 154 |
| Nerve agent exposure | peds | 15–25 mg/kg | IV/IO/IM | not captured | standing | page 154 |
Promethazine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nausea / vomiting | adult | 12.5 mg | IV/IO/IM | not captured | standing | page 13 |
| Nausea / vomiting | adult | 25 mg | IV/IM | not captured | standing | page 164 |
S–Z Sodium Bicarbonate1
Sodium Bicarbonate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hyperkalemia | adult | 50 mEq | IV/IO | not captured | standing | page 91 |
| Hyperkalemia | peds | 1 mEq/kg | IV/IO | not captured | standing | page 91 |
| Tricyclic overdose | adult | 50 mEq | IV/IO | not captured | standing | page 152 |
| Tricyclic overdose | peds | 1 mEq/kg | IV/IO | not captured | standing | page 152 |
Cite this
Nash County Emergency Medical Services, United States EMS Protocol Census. 118 dose entries, effective 2022-01-01.
https://protoquiz.com/census/agencies/nash-county-emergency-medical-services/
The census is free and not for sale. Only public agencies are named.